IL123414A0 - Optically active phenyl pyrimidine derivative its preparation and pharmaceutical compositions containing it - Google Patents

Optically active phenyl pyrimidine derivative its preparation and pharmaceutical compositions containing it

Info

Publication number
IL123414A0
IL123414A0 IL12341496A IL12341496A IL123414A0 IL 123414 A0 IL123414 A0 IL 123414A0 IL 12341496 A IL12341496 A IL 12341496A IL 12341496 A IL12341496 A IL 12341496A IL 123414 A0 IL123414 A0 IL 123414A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
optically active
compositions containing
pyrimidine derivative
Prior art date
Application number
IL12341496A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL123414A0 publication Critical patent/IL123414A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL12341496A 1995-09-05 1996-09-03 Optically active phenyl pyrimidine derivative its preparation and pharmaceutical compositions containing it IL123414A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9518027.9A GB9518027D0 (en) 1995-09-05 1995-09-05 Pharmacologically active compound
PCT/EP1996/003856 WO1997009317A2 (fr) 1995-09-05 1996-09-03 Derive phenylpyrimidine actif optiquement utilise en tant qu'agent analgesique

Publications (1)

Publication Number Publication Date
IL123414A0 true IL123414A0 (en) 1998-09-24

Family

ID=10780172

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12341496A IL123414A0 (en) 1995-09-05 1996-09-03 Optically active phenyl pyrimidine derivative its preparation and pharmaceutical compositions containing it

Country Status (32)

Country Link
US (1) US6124308A (fr)
EP (1) EP0879230B1 (fr)
JP (1) JPH11512108A (fr)
KR (1) KR19990044397A (fr)
CN (1) CN1200729A (fr)
AP (1) AP640A (fr)
AR (1) AR004192A1 (fr)
AT (1) ATE203523T1 (fr)
AU (1) AU710091B2 (fr)
BG (1) BG65102B1 (fr)
BR (1) BR9610388A (fr)
CA (1) CA2230362A1 (fr)
CO (1) CO4750651A1 (fr)
CZ (1) CZ65598A3 (fr)
DE (1) DE69614150T2 (fr)
EA (1) EA000695B1 (fr)
ES (1) ES2160834T3 (fr)
GB (1) GB9518027D0 (fr)
HR (1) HRP960399A2 (fr)
HU (1) HUP9901260A3 (fr)
ID (1) ID17274A (fr)
IL (1) IL123414A0 (fr)
IS (1) IS4673A (fr)
NO (1) NO980923L (fr)
NZ (1) NZ318390A (fr)
PL (1) PL325329A1 (fr)
SK (1) SK28598A3 (fr)
TR (1) TR199800386T1 (fr)
TW (1) TW367326B (fr)
WO (1) WO1997009317A2 (fr)
YU (1) YU49796A (fr)
ZA (1) ZA967466B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR016212A1 (es) * 1998-04-28 2001-06-20 Astra Ab Uso de compuestos farmaceuticos que tienen una actividad antagonista de nmda para preparar un medicamento para el tratamiento del sindrome de intestino irritable (ibs), y composiciones farmaceuticas
WO1999064045A1 (fr) * 1998-06-08 1999-12-16 Advanced Medicine, Inc. Agents therapeutiques agissant sur les transporteurs membranaires
US6420354B1 (en) 1998-06-08 2002-07-16 Advanced Medicine, Inc. Sodium channel drugs and uses
GB9907965D0 (en) * 1999-04-09 1999-06-02 Glaxo Group Ltd Medical use
US6479498B1 (en) 1999-06-04 2002-11-12 Theravance, Inc. Sodium channel drugs and uses
WO2002007822A2 (fr) * 2000-07-21 2002-01-31 Ortho-Mcneil Pharmaceutical, Inc. Composes de carbamate destines a la prevention ou au traitement de douleurs neuropathiques et de douleurs associees a la cephalee vasculaire de horton et a la migraine
IL157608A0 (en) * 2001-02-27 2004-03-28 Teva Pharma New crystal forms of lamotrigine and processes for their preparations
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
AU2003234240A1 (en) * 2002-04-23 2003-11-10 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing lamotrigine particles of defined morphology
JP2006515326A (ja) * 2003-01-30 2006-05-25 ダイノジェン ファーマシューティカルズ, インコーポレイテッド 胃腸管障害を処置するためのナトリウムチャネルモジュレーターの使用
GB0603087D0 (en) * 2006-02-15 2006-03-29 Glaxo Group Ltd Novel use
JP2010516731A (ja) 2007-01-24 2010-05-20 グラクソ グループ リミテッド 2−メトキシ−5−(5−トリフルオロメチル−テトラゾール−1−イル)−ベンジル]−(2s−フェニル−ピペリジン−3s−イル)−アミンを含む医薬組成物
GB201111712D0 (en) 2011-07-08 2011-08-24 Gosforth Ct Holdings Pty Ltd Pharmaceutical compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0021121B1 (fr) * 1979-06-01 1983-05-11 The Wellcome Foundation Limited Dérivés de la triazine-1,2,4, procédé pour la préparation de tels composés et compositions pharmaceutiques les contenant
FI895821A7 (fi) * 1988-12-07 1990-06-08 The Wellcome Foundation Ltd Farmaseuttisesti aktivisia CNS-yhdisteitä

Also Published As

Publication number Publication date
SK28598A3 (en) 1998-09-09
TW367326B (en) 1999-08-21
CA2230362A1 (fr) 1997-03-13
JPH11512108A (ja) 1999-10-19
HUP9901260A3 (en) 2001-04-28
IS4673A (is) 1998-02-23
TR199800386T1 (xx) 1998-05-21
KR19990044397A (ko) 1999-06-25
AP9600857A0 (en) 1996-10-31
EA199800189A1 (ru) 1998-10-29
MX9801680A (es) 1998-05-31
HUP9901260A2 (hu) 1999-09-28
HRP960399A2 (en) 1998-04-30
BR9610388A (pt) 1999-07-06
CZ65598A3 (cs) 1998-07-15
CN1200729A (zh) 1998-12-02
NO980923D0 (no) 1998-03-04
AU6986596A (en) 1997-03-27
BG65102B1 (bg) 2007-02-28
ATE203523T1 (de) 2001-08-15
WO1997009317A3 (fr) 1997-04-03
AR004192A1 (es) 1998-11-04
EP0879230B1 (fr) 2001-07-25
EP0879230A2 (fr) 1998-11-25
NO980923L (no) 1998-05-04
AP640A (en) 1998-04-14
PL325329A1 (en) 1998-07-20
ID17274A (id) 1997-12-18
ZA967466B (en) 1998-04-06
DE69614150T2 (de) 2001-11-22
EA000695B1 (ru) 2000-02-28
WO1997009317A2 (fr) 1997-03-13
US6124308A (en) 2000-09-26
DE69614150D1 (de) 2001-08-30
ES2160834T3 (es) 2001-11-16
NZ318390A (en) 1999-02-25
AU710091B2 (en) 1999-09-16
CO4750651A1 (es) 1999-03-31
GB9518027D0 (en) 1995-11-08
BG102342A (en) 1998-09-30
YU49796A (sh) 1999-07-28

Similar Documents

Publication Publication Date Title
EP1001813B8 (fr) Formulations pharmaceutiques contenant du voriconazole
AU1157599A (en) Pyrimidinone compounds and pharmaceutical compositions containing them
IL119078A (en) Substituted benzylaminopiperidine compounds and pharmaceutical compositions comprising them
IL124214A (en) Stable freeze-dried pharmaceutical formulation
IL116957A0 (en) Substituted heterocyclic compounds their preparation and pharmaceutical compositions containing them
AU6613996A (en) Heterocyclic compounds and pharmaceutical compositions containing them
IL116851A (en) 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them
AP9600883A0 (en) Pharmaceutical formulations
IL117860A0 (en) Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them
IL122618A0 (en) Substituted imidazolylacetonitrile compounds their preparation and pharmaceutical compositions containing them
IL122293A0 (en) Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them
AP9701160A0 (en) Compounds and pharmaceutical compositions containing them
IL122705A (en) 2-(4-Susbstituted)-benzylamino-2-methyl-propanamide derivatives their preparation and pharmaceutical compositions containing them
IL117554A0 (en) Imidazoquinazolines their preparation and pharmaceutical compositions containing them
HUP9800147A3 (en) Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them
IL117050A0 (en) Solid active ingredient compositions containing hydroxypropylcellulose
HUP0100085A3 (en) Biphenylamidine derivatives and pharmaceutical compositions containing them
IL134538A (en) Lactacystin derivatives and pharmaceutical compositions containing the same
IL118672A (en) Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them
IL119371A0 (en) Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them
HUP9903526A3 (en) Pyrimidine derivatives and pharmaceutical compositions containing the same
AU1172097A (en) Pharmaceutical composition containing trehalose
HUP9802291A3 (en) Penicillaminamide derivatives and pharmaceutical compositions containing them
IL123424A0 (en) Heterocyclic compounds their preparation and pharmaceutical compositions containing them
AU3459697A (en) Novel pyrimidine compounds and drug compositions